Blog

To MBA or not to MBA: is that the question?

“What kind of CEO do you want to be?” That question still rings in my head.

It came after a meeting with a CEO that I’d attended with my dad, one in a string of meetings to match small biotech and health tech companies with potential investors.

My dad, an investor, was letting me flex some muscle. I had hopped straight from earning a PhD in biomedical engineering to consulting at McKinsey – and now, I knew just the questions to ask: if it was a cell therapy or biologic, I’d hammer them on manufacturing or the regulatory process. If it were a device, I’d ask about IP or competition.

Over time, I noticed a pattern in the answers. If the CEO were, say, an MD, he or she would demonstrate less fluency with the financials. And if it were a lawyer at the helm, I’d note the micro-stuttering of a person for whom technology was a “second language” – in other words, someone who’d been taught (rather than having developed) the technology’s mechanism of action.

Read More

Dr. Who?: The Art & Science of Hiring

EpiBone is hiring! Which shifts my mind from the usual scientific questions of “What,” “Why,” and “How” to the often more challenging question of “Who?” Who best suits a certain role? Who completes a team? Who is who they seem to be?A seasoned entrepreneur/investor, Cyrus Massoumi of Zocdoc, recently led me one step closer to an answer. While we were chatting on the phone, Cyrus said, “If I could recommend you read one single book, Who (by Geoff Smart and Randy Street) would be it.”

Read More

Spark of insight: Biofabricate, Autodesk, And Blending of Art and Science

EpiBone is participating this week in the BioFabricate conference, an international gathering at Microsoft Technology Center in New York City to showcase cutting-edge progress in what we can build with living materials. So I’m feeling extra celebratory about the growing synergy between biology and design.

At EpiBone, we’ve solidified the connection between creativity and science with our artist-in-residence program—that’s what we’re spotlighting at the conference. But we’re hardly the only ones blending art and science.

Read More

Bridging Art & Science: EpiBone’s First Artist in Residence

This summer EpiBone launched an artist in residence program dedicated to exploration in biodesign and biofabrication.

As the first artist in resident, Maia Yoshida reflects on her experience, lessons learned and her role in defining this position. We look forward continuing this program and open our doors to more multidisciplinary artists and scientists.

What is an artist doing working in a cutting-edge science lab?

That’s a question I hear almost every time I explain my summer internship at EpiBone. Fortunately, I feel my whole life has been preparing me to answer it.

I have always sat firmly at the intersection between art and science. My best subjects in school were the visual arts and the natural sciences, a seemingly unlikely pair. Many people view art and science as separate entities, rarely intersecting, but yet, I constantly found myself exploring their connections anyway. In high school, I wrote an essay on how Vincent van Gogh’s mental illness influenced his artwork and, at the University of Pennsylvania, I began illustrating and designing the layout for Synapse Magazine, a student-run healthcare publication. However, with each of these endeavors, I felt as though I was only learning about art and science in parallel. Then, I was assigned to design the layout for an article called “Designer Bones,” and I discovered EpiBone.

Read More